|
Play Video: The Importance of Insider Buying
|
|
|
The table below summarizes the most recent Healthcare Realty Trust insider buying information, with links below the price to see the
CAGR achieved by each insider on their purchases. As the saying goes on Wall St., there are many
possible reasons to sell a stock, but only one reason to buy. Watch the importance of insider buying video for more
information about why Healthcare Realty Trust insider buys are important for investors to follow.
Date | Insider | Price | Amount |
8-16-2023 Insider Buy |
John Knox Singleton Director |
$17.11
CAGR »
|
$538,965.00 31,500 shares |
3-8-2023 Insider Buy |
James Joseph Kilroy IV Director |
$19.02
CAGR »
|
$45,646.80 2,400 shares |
3-6-2023 Insider Buy |
James Joseph Kilroy IV Director |
$19.27
CAGR »
|
$192,700.00 10,000 shares |
3-5-2021 Insider Buy |
Edward Hall Braman Director |
$28.89
CAGR »
|
$57,780.00 2,000 shares |
8-21-2020 Insider Buy |
Edward Hall Braman Director |
$27.85
CAGR »
|
$55,697.00 2,000 shares |
8-10-2020 Insider Buy |
Edward Hall Braman Director |
$29.00
CAGR »
|
$101,517.50 3,500 shares |
8-15-2017 Insider Buy |
John Knox Singleton Director |
$31.88
CAGR »
|
$109,986.00 3,450 shares |
2-28-2017 Insider Buy |
Nancy H. Agee Director |
$32.18
CAGR »
|
$74,333.49 2,310 shares |
3-1-2017 Insider Buy |
John Knox Singleton Director |
$31.86
CAGR »
|
$502,535.05 15,773 shares |
11-10-2016 Insider Buy |
David R. Emery Chairman/CEO |
$27.66
CAGR »
|
$1,991,241.39 72,000 shares |
11-9-2016 Insider Buy |
David R. Emery Chairman/CEO |
$28.84
CAGR »
|
$1,961,045.20 68,000 shares |
9-13-2016 Insider Buy |
Nancy H. Agee Director |
$33.68
CAGR »
|
$37,050.75 1,100 shares |
6-9-2016 Insider Buy |
John Knox Singleton Director |
$31.78
CAGR »
|
$166,304.41 5,233 shares |
8-10-2015 Insider Buy |
John Knox Singleton Director |
$24.25
CAGR »
|
$10,000.00 412 shares |
8-3-2015 Insider Buy |
John Knox Singleton Director |
$24.04
CAGR »
|
$9,999.99 416 shares |
3-10-2015 Insider Buy |
John Knox Singleton Director |
$26.42
CAGR »
|
$10,000.00 379 shares |
1-1-2015 Insider Buy |
B. Douglas Whitman II Executive V.P. - Corp Finance |
$18.11
CAGR »
|
$21,243.03 1,173 shares |
9-30-2014 Insider Buy |
John M. Bryant Jr. Executive Vice President & GC |
$18.11
CAGR »
|
$21,243.03 1,173 shares |
3-31-2014 Insider Buy |
John M. Bryant Jr. Executive Vice President & GC |
$15.80
CAGR »
|
$21,235.20 1,344 shares |
1-1-2014 Insider Buy |
Scott W. Holmes Executive Vice President & CFO |
$15.80
CAGR »
|
$21,235.20 1,344 shares |
1-1-2013 Insider Buy |
B. Douglas Whitman II Executive V.P. - Corp Finance |
$15.80
CAGR »
|
$21,235.20 1,344 shares |
8-10-2011 Insider Buy |
John Knox Singleton Director |
$16.00
CAGR »
|
$12,800.00 800 shares |
8-11-2011 Insider Buy |
John Knox Singleton Director |
$15.54
CAGR »
|
$31,070.00 2,000 shares |
8-11-2011 Insider Buy |
Roger O. West Director |
$15.76
CAGR »
|
$24,892.90 1,580 shares |
6-6-2011 Insider Buy |
Roger O. West Director |
$20.96
CAGR »
|
$49,256.00 2,350 shares |
12-17-2010 Insider Buy |
John Knox Singleton Director |
$20.37
CAGR »
|
$20,368.00 1,000 shares |
5-25-2010 Insider Buy |
Roger O. West Director |
$20.96
CAGR »
|
$99,769.60 4,760 shares |
1-28-2010 Insider Buy |
Dan S. Wilford Director |
$21.36
CAGR »
|
$15,914.03 745 shares |
Also See: Institutional Holders of HR
Also See: SEC filings
Below we present the annualized performance delivered by Healthcare Realty Trust stock since 8-16-2023 (the date of the most recent
insider purchase). The performance of the investment from the time Healthcare Realty Trust insider buying occurred is the ultimate
test of whether insiders were right about HR being a good buy.
Growth of $10,000.00
With Dividends Reinvested
|
Start date: |
08/17/2023 |
|
End date: |
05/06/2024 |
|
Start price/share: |
$16.91 |
|
End price/share: |
$14.99 |
|
Starting shares: |
591.37 |
|
Ending shares: |
618.45 |
|
Dividends reinvested/share: |
$0.62 |
|
Total return: |
-7.29% |
|
Annualized Gain: |
-10.12% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$9,271.00 |
|
Years: |
0.72 |
|
|
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
08/17/2023 |
|
End date: |
05/06/2024 |
|
Start price/share: |
$16.91 |
|
End price/share: |
$14.99 |
|
Dividends collected/share: |
$0.62 |
|
Total return: |
-7.69% |
|
Annualized Gain: |
-10.67% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$9,231.00 |
|
Years: |
0.72 |
|
Healthcare Realty Trust Insider Buying
This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.),
and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these
categories, but instead file their holdings quarterly on the latest form 13F filings.
While recent Healthcare Realty Trust insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).
Also See: Funds Holding HR
|
|